We understand the complexity of inhalation and nasal delivered therapies. Our team combines deep scientific expertise with regulatory insight to deliver reliable, scalable solutions. Resyca’s technology is clinically validated and certified to meet global standards, including ISO 13485 and EU MDR.

Whether you’re developing a biologic, small molecule or nose-to-brain therapy, we provide the technical foundation and strategic support for your needs.

We don’t overpromise. We deliver. Our approach is grounded in transparency, quality, and long-term thinking.

We take pride in being a trusted partner to pharmaceutical innovators, helping them navigate development challenges with confidence.

Resyca is more than a technology provider—we’re a development partner. We work closely with pharma and biotech companies across Europe, North America, and Asia to co-create tailored solutions.

Our collaborations span formulation, device integration, clinical validation, and regulatory strategy. 

We move fast, learn quickly, and solve problems with precision. Our proprietary platforms – Pulmospray® and PFSI™ – enable needle-free, soft mist delivery using standard pre-filled syringes.

These systems are compatible with GMP filling lines and suitable for pulmonary, nasal, and nose-to-brain applications.

Clinical validation demonstrates the therapeutic potential and reliability of our technology.